Sinphar Pharmaceutical Co Ltd

Sinphar Pharmaceutical Co Ltd

1734 · TW · Healthcare / Biotechnology

30.05TWD+0.05 (+0.17%)

Price History

Full chart

Market Stats

Previous Close30.00
Open30.00
Day Range30.00 – 30.25
52-Week Range29.30 – 34.55
Volume129.69K
Market Cap6.84B
P/E (TTM)19.51
Forward P/E23.64
EPS1.64
Dividend Yield2.94%
Beta0.09
50-Day Avg30.78
200-Day Avg28.58

About

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Zhiwen Li
  • Employees0
  • HeadquartersNo. 84, Zhongshan Road, Yilan City, Taiwan, 269, Taiwan
  • Websitehttps://www.sinphar.com.tw

Leadership

  • Mr. Zhiwen LiFounder
  • Youyang BaiGeneral Manager
  • Qing ChenAccountant
  • Hsin Huang Wen Ph.D.VP and Chief R&D Officer

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue916.24M1.11B1.41B1.71B1.64B1.76B1.81B1.81B1.82B1.84B2.09B2.58B2.64B2.19B2.13B2.13B2.22B2.39B2.39B2.43B2.86B2.96B3.15B3.37B
Growth (%)-+21.35%+26.73%+21.65%-4.42%+7.72%+2.58%+0.17%+0.51%+0.97%+13.39%+23.54%+2.49%-17.21%-2.46%+0.03%+3.83%+8.07%-0.26%+1.89%+17.39%+3.72%+6.33%+7.00%
Cost of Revenue453.63M568.88M789.37M973.20M964.85M1.10B1.18B1.09B1.13B1.15B1.31B1.61B1.56B1.40B1.34B1.32B1.39B1.45B1.51B1.54B1.77B1.87B1.91B1.91B
Gross Profit--619.73M740.92M673.56M666.64M628.63M723.89M694.17M693.80M773.84M964.28M1.08B785.98M789.91M810.26M825.38M940.85M875.53M888.71M1.09B1.09B1.24B1.46B
Gross Margin--43.98%43.22%41.11%37.77%34.72%39.92%38.09%37.70%37.09%37.41%41.01%35.93%37.02%37.97%37.25%39.29%36.66%36.52%38.20%36.83%39.26%43.21%
Operating Expense--474.07M600.13M616.00M569.22M565.54M588.98M596.83M631.16M647.66M801.77M939.33M914.25M932.07M873.29M944.68M1.09B997.73M1.07B893.50M805.19M943.01M1.04B
Operating Income70.35M86.79M145.65M140.79M57.56M97.42M63.09M134.91M97.34M62.65M126.19M162.51M144.30M-128.27M-142.16M-63.03M-119.30M-145.75M-122.20M-180.23M197.80M286.06M294.01M416.86M
Operating Margin7.68%7.81%10.34%8.21%3.51%5.52%3.48%7.44%5.34%3.40%6.05%6.30%5.46%-5.86%-6.66%-2.95%-5.38%-6.09%-5.12%-7.41%6.92%9.65%9.33%12.36%
EBITDA--229.94M271.22M143.88M208.57M191.26M293.90M282.12M266.20M328.51M596.89M420.64M188.42M246.21M206.91M171.56M173.18M157.16M109.64M539.57M582.94M601.24M689.70M
EBITDA Margin--16.32%15.82%8.78%11.82%10.56%16.21%15.48%14.47%15.74%23.15%15.92%8.61%11.54%9.70%7.74%7.23%6.58%4.51%18.89%19.67%19.08%20.46%
Net Income62.06M70.91M121.94M155.35M43.88M80.63M46.18M131.03M110.93M72.23M124.38M300.69M163.39M13.95M16.55M36.73M8.79M13.96M-28.51M-38.13M224.64M375.17M304.70M365.75M
Net Income Margin6.77%6.38%8.65%9.06%2.68%4.57%2.55%7.23%6.09%3.92%5.96%11.66%6.18%0.64%0.78%1.72%0.40%0.58%-1.19%-1.57%7.86%12.66%9.67%10.85%
R&D68.28M75.79M95.26M99.21M121.52M125.52M128.03M133.48M151.96M185.20M175.71M225.85M350.27M343.40M382.61M363.49M376.38M527.80M462.40M511.88M272.16M132.58M151.36M145.37M
R&D as % of Total Revenue7.45%6.82%6.76%5.79%7.42%7.11%7.07%7.36%8.34%10.06%8.42%8.76%13.26%15.70%17.93%17.03%16.99%22.04%19.36%21.03%9.53%4.47%4.80%4.31%
Interest Expense0019.45M14.91M16.67M19.79M34.66M21.11M13.36M14.67M17.19M18.56M20.27M20.67M21.80M20.74M20.44M23.12M24.51M24.80M27.81M33.71M36.77M33.85M
Interest Expense % of Total Revenue0.00%0.00%1.38%0.87%1.02%1.12%1.91%1.16%0.73%0.80%0.82%0.72%0.77%0.95%1.02%0.97%0.92%0.97%1.03%1.02%0.97%1.14%1.17%1.00%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.65B2.06B2.35B2.84B2.77B3.16B3.59B3.58B3.71B4.64B4.54B5.70B6.46B6.39B6.21B6.04B5.88B5.92B6.13B6.22B6.19B6.25B6.30B6.15B
Total Liabilities776.65M1.12B1.03B1.19B1.11B1.46B1.82B1.49B1.55B1.98B1.85B2.21B2.39B2.43B2.42B2.42B2.46B2.71B2.98B3.14B2.97B2.85B2.75B2.44B
Total Equity875.36M942.90M1.19B1.50B1.50B1.54B1.61B1.95B2.03B2.48B2.53B3.01B3.30B3.22B3.09B3.07B2.93B2.78B2.74B2.72B2.93B3.10B3.26B3.44B
Cash100.58M278.80M275.31M484.64M234.38M281.05M7.61M398.26M424.25M911.18M517.02M756.38M1.26B917.01M1.09B1.07B958.52M840.72M1.14B1.19B1.24B1.07B1.08B864.14M
Total Debt--665.72M835.59M836.63M1.15B1.31B1.07B1.12B1.47B1.33B1.42B1.54B1.51B1.60B1.67B1.72B1.94B2.16B2.13B1.91B1.95B1.90B1.51B
Net Debt--665.72M835.59M836.63M1.15B1.30B668.41M693.14M555.80M809.82M667.35M279.01M594.66M505.32M594.82M761.02M1.10B1.01B939.62M675.96M870.53M827.06M645.77M

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-120.84M174.81M122.09M166.57M174.85M271.01M309.94M261.49M225.58M164.45M297.09M148.58M280.53M87.18M219.87M79.50M-79.49M146.39M135.54M425.30M296.37M593.51M584.66M
Investing Cash Flow-------393.67M-187.45M-309.86M-405.34M-372.43M-617.70M-369.48M-480.29M-13.20M-226.70M-179.41M-210.84M-165.68M-205.60M-124.24M-334.56M-391.08M-224.63M
Financing Cash Flow257.12M193.13M67.81M332.02M-314.58M267.40M-133.30M77.65M723.49M-184.34M554.27M618.37M-124.22M130.69M-13.61M-8.28M182.21M318.73M122.95M-263.32M-106.84M-209.08M-576.03M
Capital Expenditure165.58M260.50M160.79M188.76M249.44M414.90M233.25M219.71M292.75M361.69M375.19M598.16M294.29M412.04M224.85M171.00M255.69M176.73M157.77M161.44M153.44M300.94M256.71M200.94M
Free Cash Flow------37.75M90.23M-31.26M-136.11M-210.75M-301.07M-145.71M-131.51M-137.66M48.87M-176.19M-256.22M-11.38M-25.90M271.85M-4.57M336.80M383.72M
Dividends Paid10.25M19.29M23.26M36.98M-54.88M68.75M37.42M66.54M83.04M52.26M89.59M119.46M129.02M32.25M16.77M33.54M16.77M33.55M33.54M33.54M167.72M167.72M181.14M
FCF to OCF------13.93%29.11%-11.95%-60.34%-128.15%-101.34%-98.07%-46.88%-157.90%22.23%-221.62%322.35%-7.77%-19.11%63.92%-1.54%56.75%65.63%
Dividend Paid to FCF------182.10%41.47%-212.90%-61.01%-24.80%-29.76%-81.98%-98.11%-23.43%34.32%-19.04%-6.55%-294.82%-129.51%12.34%-3673.28%49.80%47.21%

Earnings

Report DateApr 29, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Apr 30, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Jun 1, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Oct 31, 2012Feb 27, 2013May 15, 2013Aug 13, 2013Nov 13, 2013Feb 26, 2014May 14, 2014Aug 13, 2014Nov 13, 2014Feb 25, 2015May 14, 2015Aug 13, 2015Nov 15, 2015Mar 30, 2016May 13, 2016Aug 15, 2016Nov 14, 2016Mar 30, 2017May 13, 2017Aug 10, 2017Nov 13, 2017Mar 30, 2018May 14, 2018Aug 14, 2018Nov 14, 2018Mar 28, 2019Apr 1, 2019Aug 28, 2019Nov 27, 2019Mar 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Jun 2, 2021Sep 1, 2021Dec 1, 2021Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 29, 2023May 31, 2023Aug 15, 2023Mar 20, 2025May 12, 2025
EPS Estimate0.13---0.08-------------0.09-0.160.150.35-0.370.380.22-0.340.000.11------0.010.10---------------------0.450.41
EPS Actual0.070.120.030.090.080.260.190.210.240.260.100.150.160.140.090.100.130.220.020.040.600.290.440.190.300.35-0.110.32-0.13-0.05-0.080.40-0.10-0.01-0.040.25-0.050.050.070.130.10-0.01-0.090.050.09-0.15-0.060.210.160.05-0.060.030.03-0.200.350.520.410.070.480.650.400.59
Surprise-46.15%---0.00%--------------77.78%-275.00%93.33%25.71%--18.92%-7.89%-150.00%--138.24%--172.73%------400.00%-30.00%----------------------11.11%43.90%
TimingAfter-hours---Pre-market-------------After-hours-After-hoursPre-marketPre-market-After-hoursPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-market---------------Pre-marketAfter-hours

Key Statistics & Ratios

Market Cap6.84B
Enterprise Value7.31B
Trailing P/E19.51
Forward P/E23.64
PEG Ratio1.85
Price / Sales1.98
Price / Book1.99
EPS1.64
Book Value17.11
Revenue (TTM)3.45B
Gross Profit (TTM)1.54B
EBITDA653.96M
Profit Margin10.19%
Operating Margin12.83%
Return on Equity9.42%
Return on Assets3.96%
Shares Outstanding213.71M
Shares Float141.63M
Beta0.09
Dividend Yield2.94%
Dividend Rate0.94
Payout Ratio51.59%

Dividends

20231×
1.00Jul 13, 2023
20221×
0.20Jul 21, 2022
20211×
0.20Aug 31, 2021
20201×
0.20Jul 23, 2020
20191×
0.10Jul 17, 2019
20181×
0.20Jul 23, 2018
20171×
0.10Jul 11, 2017
20161×
0.20Sep 1, 2016
20151×
0.77Jul 30, 2015
20141×
0.71Jul 3, 2014
20131×
0.53Jul 9, 2013
20121×
0.31Jul 19, 2012
20111×
0.57Jul 15, 2011
20101×
0.48Jul 27, 2010
20091×
0.28Jul 28, 2009
20081×
0.54Jul 24, 2008
20071×
0.42Jul 19, 2007
20061×
0.39Jun 29, 2006
20051×
0.32Jun 16, 2005
20041×
0.21Jun 17, 2004
20031×
0.27Jul 10, 2003
20021×
0.13May 21, 2002

Stock Splits

  • Sep 1, 201626:25
  • Aug 28, 201427:25
  • Nov 15, 20111441:1414
  • Jul 27, 2010683:660
  • Aug 3, 200627:25
  • Sep 14, 20054013:3892
  • Jul 13, 2005107:100
  • Jun 17, 200453:50
  • Mar 12, 20041895:1872
  • Jul 10, 200321:20
  • May 21, 2002970:893
  • Aug 16, 200153:50
  • Feb 6, 2001253:250